Market Overview

Benzinga's Volume Movers

Related XOOM
Is Xoom Really A Threat To PayPal? Gene Munster Digs In
Benzinga's Top Downgrades
Related GALT
Morning Market Losers
Galectin Therapeutics' Executive Chairman to Discuss Silent Epidemic and Company's Role in Developing Treatments for NASH and Other Diseases at Robins Equity Research Roundup Conference

Xoom (NASDAQ: XOOM) shares moved up 3.75% to $31.83. The volume of Xoom shares traded was 1988% higher than normal. Xoom priced its follow-on offering of 4,403,270 shares of its common stock at a price of $30.50 per share.

Galectin Therapeutics (NASDAQ: GALT) shares rose 23.52% to $10.59. The volume of Galectin Therapeutics shares traded was 760% higher than normal. Galectin Therapeutics received US Patent for the potential treatment for fatty liver disease.

Lannett Company (NYSE: LCI) shares climbed 5.03% to $16.49. The volume of Lannett shares traded was 669% higher than normal. Lannett reported upbeat Q4 results.

SYNNEX (NYSE: SNX) surged 19.39% to $57.27. The volume of SYNNEX shares traded was 489% higher than normal. SYNNEX announced its plans to buy IBM's customer care unit for $505 million.

Posted-In: volume moversNews Intraday Update Markets Movers


Related Articles (LCI + GALT)

View Comments and Join the Discussion!

Get Benzinga's Newsletters